Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Anthera Pharmaceuticals, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2022 | $50.03M | $50.03M - $50.03M | $10.01M | $0.15 | 1 |
| Dec 2021 | $24.52M | $24.52M - $24.52M | $4.90M | -$0.79 | 1 |
| Dec 2020 | $14.43M | $14.43M - $14.43M | $2.88M | -$1.18 | 1 |
| Dec 2019 | $4.78M | $4.78M - $4.78M | $956.4K | -$1.54 | 1 |
| Dec 2018 | $0.00 | $0.00 - $0.00 | $0.00 | -$2.19 | 0 |
| Dec 2017 | $0.00 | $0.00 - $0.00 | $0.00 | -$2.973 | 0 |
| Dec 2016 | $122.5K | $122.5K - $122.5K | -$45.29M | -$12.263 | 1 |
| Dec 2015 | $1.38M | $1.38M - $1.38M | $275.9K | -$8.672 | 1 |